FPI Stock Recent News

Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies SAN DIEGO , Nov. 11, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced enrollment of the first patient in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® (pembrolizumab) or Opdivo® (nivolumab) (AEMD-2022-06 Hemopurifier Study). The patient was enrolled on October 29, 2024, by Prof.

Farmland Partners, Inc. (NYSE:FPI ) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET Company Participants Christine Garrison - General Counsel Luca Fabbri - President and CEO Paul Pittman - Executive Chairman Susan Landi - Chief Financial Officer Conference Call Participants Robert Stevenson - Janney Scott Fortune - ROTH Capital Partners Buck Horne - Raymond James John Massocca - B. Riley Craig Kucera - Lucid Capital Markets Operator Thank you for standing by.

While the top- and bottom-line numbers for Farmland Partners (FPI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Farmland Partners (FPI) came out with quarterly funds from operations (FFO) of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.01 per share a year ago.

REITs have surged by nearly 40% on average. But some specific REITs missed out on this rally. I highlight 2 REITs that still present significant upside potential.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company”) today announced it will release its financial results for the quarter ended September 30, 2024, after 5 p.m. (Eastern Time) on Wednesday, October 30, 2024, and will host a conference call the following day, Thursday, October 31, 2024, at 11:00 a.m. (Eastern Time) to discuss the financial results and provide a company update. The call can be accessed live over the phone by dialing 1-800-715-9871 and using the conference.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company” or “FPI”) today confirmed that the recently announced sale of a portfolio of farmland to Farmland Reserve, Inc. (“Farmland Reserve”) closed as scheduled on October 16, 2024 (the “Transaction”). The portfolio sold to Farmland Reserve consisted of 46 farms, comprising 41,554 acres of farmland in Arkansas, Florida, Louisiana, Mississippi, Nebraska, Oklahoma, and the Carolinas. The $289 million all-cash Transaction generated.

Farmland Partners' recent sale of 41,554 acres at a 61% premium to USDA values highlights its NAV at $17-$21 per share, well above market price. This sale disproves bear claims, showing FPI's land quality and potential for higher value, especially with remaining high-value assets in Illinois and California. FPI's net asset value is roughly 70% higher than its market price, offering potential returns from portfolio sales, asset sales with buybacks, or continued operations.

DENVER--(BUSINESS WIRE)--Farmland Partners Inc. (NYSE: FPI) (the “Company” or “FPI”) today announced that it is selling a portfolio of 46 farms, comprising 41,554 acres of farmland (the “Portfolio”), for $289 million in a single transaction (“the “Transaction”) with Farmland Reserve, Inc. The all-cash deal has been finalized by both parties and is scheduled to close on October 16, 2024, once all conditions to closing are satisfied. The Portfolio includes farms across several regions and states,.

My portfolio has done very well lately. But I have had quite a few setbacks in recent years. I review some of my worst REIT investments ever.